StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health cash

Cash and short-term investments held at the end of each period.

Phibro Animal Health's cash was $81.99M at Jun 30, 2026. For fiscal 2026 it was $81.99M, up 6.4% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $114.61M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$81.99M+6.4%
FY2025Jun 30, 2025$77.04M-32.8%
FY2024Jun 30, 2024$114.61M+41.0%
FY2023Jun 30, 2023$81.28M-10.9%
FY2022Jun 30, 2022$91.25M-0.4%
FY2021Jun 30, 2021$91.60M+0.3%
FY2020Jun 30, 2020$91.34M+12.0%
FY2019Jun 30, 2019$81.57M+3.0%
FY2018Jun 30, 2018$79.17M+41.2%
FY2017Jun 30, 2017$56.08M+66.9%
FY2016Jun 30, 2016$33.61M+15.0%
FY2015Jun 30, 2015$29.22M+147.2%
FY2014Jun 30, 2014$11.82M-56.8%
FY2013Jun 30, 2013$27.37M-49.2%
FY2012Jun 30, 2012$53.90M+10.9%
FY2011Jun 30, 2011$48.60M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$81.99M+6.4%
Q3 FY2026CQ1 2026Mar 31, 2026$77.45M+10.1%
Q2 FY2026CQ4 2025Dec 31, 2025$74.51M+11.1%
Q1 FY2026CQ3 2025Sep 30, 2025$85.27M-5.1%
Q4 FY2025CQ2 2025Jun 30, 2025$77.04M-32.8%
Q3 FY2025CQ1 2025Mar 31, 2025$70.35M-28.8%
Q2 FY2025CQ4 2024Dec 31, 2024$67.07M-27.5%
Q1 FY2025CQ3 2024Sep 30, 2024$89.84M-1.4%
Q4 FY2024CQ2 2024Jun 30, 2024$114.61M+41.0%
Q3 FY2024CQ1 2024Mar 31, 2024$98.75M+27.8%
Q2 FY2024CQ4 2023Dec 31, 2023$92.49M+17.9%
Q1 FY2024CQ3 2023Sep 30, 2023$91.15M+5.6%
Q4 FY2023CQ2 2023Jun 30, 2023$81.28M-10.9%
Q3 FY2023CQ1 2023Mar 31, 2023$77.24M-16.8%
Q2 FY2023CQ4 2022Dec 31, 2022$78.42M-17.9%
Q1 FY2023CQ3 2022Sep 30, 2022$86.28M-11.2%
Q4 FY2022CQ2 2022Jun 30, 2022$91.25M-0.4%
Q3 FY2022CQ1 2022Mar 31, 2022$92.85M-0.3%
Q2 FY2022CQ4 2021Dec 31, 2021$95.49M-0.1%
Q1 FY2022CQ3 2021Sep 30, 2021$97.18M+5.7%
Q4 FY2021CQ2 2021Jun 30, 2021$91.60M+0.3%
Q3 FY2021CQ1 2021Mar 31, 2021$93.10M+13.9%
Q2 FY2021CQ4 2020Dec 31, 2020$95.53M+27.1%
Q1 FY2021CQ3 2020Sep 30, 2020$91.97M+16.6%
Q4 FY2020CQ2 2020Jun 30, 2020$91.34M+12.0%
Q3 FY2020CQ1 2020Mar 31, 2020$81.75M-3.7%
Q2 FY2020CQ4 2019Dec 31, 2019$75.18M-6.4%
Q1 FY2020CQ3 2019Sep 30, 2019$78.89M+4.0%
Q4 FY2019CQ2 2019Jun 30, 2019$81.57M+3.0%
Q3 FY2019CQ1 2019Mar 31, 2019$84.88M+12.3%
Q2 FY2019CQ4 2018Dec 31, 2018$80.34M+19.6%
Q1 FY2019CQ3 2018Sep 30, 2018$75.86M+22.2%
Q4 FY2018CQ2 2018Jun 30, 2018$79.17M+41.2%
Q3 FY2018CQ1 2018Mar 31, 2018$75.55M+53.2%
Q2 FY2018CQ4 2017Dec 31, 2017$67.19M+71.3%
Q1 FY2018CQ3 2017Sep 30, 2017$62.10M+66.0%
Q4 FY2017CQ2 2017Jun 30, 2017$56.08M–
Q3 FY2017CQ1 2017Mar 31, 2017$49.31M–
Q2 FY2017CQ4 2016Dec 31, 2016$39.22M–
Q1 FY2017CQ3 2016Sep 30, 2016$37.42M–

More Phibro Animal Health figures

See a number that looks wrong?